Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

Clinical trial NCT01090453 · COMPLETED

Trial details

NCT number: NCT01090453
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tetanus Hepatitis B Haemophilus Influenzae Type b Poliomyelitis Acellular Pertussis Diphtheria Neisseria Meningitidis

Start date: 2010-05-17
Primary completion: 2011-10-11
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.